180 related articles for article (PubMed ID: 16616504)
1. Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents.
Prado S; Ledeit H; Michel S; Koch M; Darbord JC; Cole ST; Tillequin F; Brodin P
Bioorg Med Chem; 2006 Aug; 14(15):5423-8. PubMed ID: 16616504
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological activity, and evaluation of the mode of action of novel antitubercular benzofurobenzopyrans substituted on A ring.
Termentzi A; Khouri I; Gaslonde T; Prado S; Saint-Joanis B; Bardou F; Amanatiadou EP; Vizirianakis IS; Kordulakova J; Jackson M; Brosch R; Janin YL; Daffé M; Tillequin F; Michel S
Eur J Med Chem; 2010 Dec; 45(12):5833-47. PubMed ID: 20961671
[TBL] [Abstract][Full Text] [Related]
3. A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial.
Alvey L; Prado S; Huteau V; Saint-Joanis B; Michel S; Koch M; Cole ST; Tillequin F; Janin YL
Bioorg Med Chem; 2008 Sep; 16(17):8264-72. PubMed ID: 18752967
[TBL] [Abstract][Full Text] [Related]
4. Identification of heteroarylenamines as a new class of antituberculosis lead molecules.
Copp BR; Christiansen HC; Lindsay BS; G Franzblau S
Bioorg Med Chem Lett; 2005 Sep; 15(18):4097-9. PubMed ID: 16005211
[TBL] [Abstract][Full Text] [Related]
5. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
6. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
7. Identification of benzofuro[2,3-b]quinoline derivatives as a new class of antituberculosis agents.
Yang CL; Tseng CH; Chen YL; Lu CM; Kao CL; Wu MH; Tzeng CC
Eur J Med Chem; 2010 Feb; 45(2):602-7. PubMed ID: 19926361
[TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.
Senthilkumar P; Dinakaran M; Chandraseakaran Y; Yogeeswari P; Sriram D
Arch Pharm (Weinheim); 2009 Feb; 342(2):100-12. PubMed ID: 19137533
[TBL] [Abstract][Full Text] [Related]
10. Ring-substituted imidazoles as a new class of anti-tuberculosis agents.
Gupta P; Hameed S; Jain R
Eur J Med Chem; 2004 Sep; 39(9):805-14. PubMed ID: 15337293
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of mycobacterial growth by plumbagin derivatives.
Mathew R; Kruthiventi AK; Prasad JV; Kumar SP; Srinu G; Chatterji D
Chem Biol Drug Des; 2010 Jul; 76(1):34-42. PubMed ID: 20456370
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimicrobial activities of some sulphur containing chromene derivatives.
Serbetçi T; Birteksöz S; Prado S; Michel S; Tillequin F
Nat Prod Commun; 2012 Jul; 7(7):891-4. PubMed ID: 22908574
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
[TBL] [Abstract][Full Text] [Related]
14. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
[TBL] [Abstract][Full Text] [Related]
15. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
[TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid.
Sriram D; Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V
J Med Chem; 2007 Nov; 50(24):6232-9. PubMed ID: 17960928
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents.
Ang W; Ye W; Sang Z; Liu Y; Yang T; Deng Y; Luo Y; Wei Y
Bioorg Med Chem Lett; 2014 Mar; 24(6):1496-501. PubMed ID: 24582981
[TBL] [Abstract][Full Text] [Related]
18. Shortening the treatment of tuberculosis.
Mitchison DA
Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
[No Abstract] [Full Text] [Related]
19. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
20. Preparation and antitubercular activities of alkylated amino alcohols and their glycosylated derivatives.
Taveira AF; Hyaric ML; Reis EF; Araújo DP; Ferreira AP; de Souza MA; Alves LL; Lourenço MC; Vicente FR; de Almeida MV
Bioorg Med Chem; 2007 Dec; 15(24):7789-94. PubMed ID: 17851083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
